WNT5A and acute kidney injury: This study evaluated the incidence of MAKE, including stage 3 AKI, initiation of RRT, and 30-day death, in patients with urosepsis, and revealed that Wnt5a levels were associated with RRT and death but not with stage 3 AKI.